[ALNY] YoY Annual Result on 31-Dec-2011 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
10-Feb-2012
Financial Year
2011
Quarter
31-Dec-2011 [#FY]
Profit Trend
YoY- -32.48%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
Revenue 50,561 47,167 66,725 82,757 100,041 100,533 96,163 -10.15%
PBT -400,604 -91,920 -116,586 -57,649 -43,001 -47,008 -25,530 58.19%
Tax -40,209 -2,695 -10,572 -5,799 514 582 719 -
NP -360,395 -89,225 -106,014 -57,649 -43,515 -47,590 -26,249 54.71%
Tax Rate - - - - - - - -
Total Cost 410,956 136,392 172,739 140,406 143,556 148,123 122,412 22.35%
Ratio Analysis
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
NP Margin -712.79 -189.17 -158.88 -69.66 -43.50 -47.34 -27.30 72.19%
Per Share
31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 CAGR
EPS -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 40.12%
EPS Diluted -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 40.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.